These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8392288

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J, Chevallier B, Metz R, Fargeot P, Pujade-Lauraine E, Spielmann M, Tubiana-Hulin M, Paes D, Bons J.
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [Abstract] [Full Text] [Related]

  • 29. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
    Hayashi Y, Iwasaka T, Hachisuga T, Fukuda K, Tanaka T, Matsuo N, Sugimori H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
    Tsavaris N, Kosmas CH, Vadiaka M, Kontos A, Katsorida M, Dimitrakopoulos A, Zerai A, Koufos CH.
    J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826
    [Abstract] [Full Text] [Related]

  • 31. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG, Gralla RJ, Clark RA, Tyson LB, Fiore JJ, Kelsen DP, Groshen S.
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [Abstract] [Full Text] [Related]

  • 32. Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Tsavaris N, Charalambidis G, Pagou M, Karabelis A, Mylonakis N, Bacoyiannis C, Kosmidis P.
    Am J Clin Oncol; 1994 Dec; 17(6):516-21. PubMed ID: 7977173
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
    De Mulder PH, Seynaeve C, Vermorken JB, van Liessum PA, Mols-Jevdevic S, Allman EL, Beranek P, Verweij J.
    Ann Intern Med; 1990 Dec 01; 113(11):834-40. PubMed ID: 2146911
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis.
    Sabbatini R, Federico M, Baldini L, Barbieri F, Maiolo MT, Silingardi V.
    Haematologica; 1995 Dec 01; 80(5):416-20. PubMed ID: 8566881
    [Abstract] [Full Text] [Related]

  • 37. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G.
    J Clin Oncol; 1991 May 01; 9(5):721-8. PubMed ID: 1826739
    [Abstract] [Full Text] [Related]

  • 38. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T, Secen N, Povazan Dj, Sabo A, Popovic J, Bursac D, Kakas M, Zaric B, Milovancev A.
    J BUON; 2007 May 01; 12(2):245-52. PubMed ID: 17600880
    [Abstract] [Full Text] [Related]

  • 39. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Smith DB, Newlands ES, Rustin GJ, Begent RH, Howells N, McQuade B, Bagshawe KD.
    Lancet; 1991 Aug 24; 338(8765):487-90. PubMed ID: 1714532
    [Abstract] [Full Text] [Related]

  • 40. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
    Hisano C, Nakano S, Okuma K, Masumoto N, Fujishima H, Nakamura M, Niho Y.
    Gan To Kagaku Ryoho; 1996 Aug 24; 23(9):1175-81. PubMed ID: 8751806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.